122 related articles for article (PubMed ID: 26513881)
1. Human papillomavirus effect on the development of endometrial polyps.
Korucuoglu U; Guler I; Dogan H; Biri A
Eur J Gynaecol Oncol; 2015; 36(5):551-3. PubMed ID: 26513881
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus as an independent risk factor of invasive cervical and endometrial carcinomas in Jordan.
Abu-Lubad MA; Jarajreh DA; Helaly GF; Alzoubi HM; Haddadin WJ; Dabobash MD; Albataineh EM; Aqel AA; Alnawaiseh NA
J Infect Public Health; 2020 Apr; 13(4):613-618. PubMed ID: 31519382
[TBL] [Abstract][Full Text] [Related]
3. Comparison of human papillomavirus DNA levels in gynecological cancers: implication for cancer development.
Yang HJ; Liu VW; Tsang PC; Yip AM; Ng TY; Cheung AN; Ngan HY
Tumour Biol; 2003; 24(6):310-6. PubMed ID: 15004491
[TBL] [Abstract][Full Text] [Related]
4. Detection of human papillomavirus DNA in malignant lesions from Chinese women with carcinomas of the upper genital tract.
Ip SM; Wong LC; Xu CM; Cheung AN; Tsang PC; Ngan HY
Gynecol Oncol; 2002 Oct; 87(1):104-11. PubMed ID: 12468350
[TBL] [Abstract][Full Text] [Related]
5. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.
Pitisuttithum P; Velicer C; Luxembourg A
Expert Rev Vaccines; 2015; 14(11):1405-19. PubMed ID: 26366475
[TBL] [Abstract][Full Text] [Related]
6. Does human papillomavirus play a role in endometrial carcinogenesis?
Fedrizzi EN; Villa LL; de Souza IV; Sebastião AP; Urbanetz AA; De Carvalho NS
Int J Gynecol Pathol; 2009 Jul; 28(4):322-7. PubMed ID: 19483634
[TBL] [Abstract][Full Text] [Related]
7. [The prevalence of human papillomaviruses in patients with colon polyps].
Mlynarczyk-Bonikowska B; Muszyński J; Szymanek-Mjchrzak K; Ziółowski B; Mlynarczyk G; Malejczyk M; Majewski L
Med Dosw Mikrobiol; 2017; 69(1):49-54. PubMed ID: 30351624
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Human Papillomavirus in endometrial cancer: a systematic review and meta-analysis.
Olesen TB; Svahn MF; Faber MT; Duun-Henriksen AK; Junge J; Norrild B; Kjaer SK
Gynecol Oncol; 2014 Jul; 134(1):206-15. PubMed ID: 24607284
[TBL] [Abstract][Full Text] [Related]
9. Cervical polyp as risk factor for hysteroscopically diagnosed endometrial polyps.
Vilodre LC; Bertat R; Petters R; Reis FM
Gynecol Obstet Invest; 1997; 44(3):191-5. PubMed ID: 9359647
[TBL] [Abstract][Full Text] [Related]
10. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
[TBL] [Abstract][Full Text] [Related]
11. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
Syrjänen KJ
Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
[TBL] [Abstract][Full Text] [Related]
12. Quadrivalent human papillomavirus vaccine.
Barr E; Tamms G
Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of endometrial polyps carried out at Ege University Hospital.
Karadadas N; Sirkeci F; Akercan F; Ulukus M; Kazandi M; Ulukus M
Clin Exp Obstet Gynecol; 2004; 31(2):137-8. PubMed ID: 15266770
[TBL] [Abstract][Full Text] [Related]
14. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases.
Skinner SR; Apter D; De Carvalho N; Harper DM; Konno R; Paavonen J; Romanowski B; Roteli-Martins C; Burlet N; Mihalyi A; Struyf F
Expert Rev Vaccines; 2016; 15(3):367-87. PubMed ID: 26902666
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus and mixed epithelial tumors of the endometrium.
O'Leary JJ; Landers RJ; Crowley M; Healy I; O'Donovan M; Healy V; Kealy WF; Hogan J; Doyle CT
Hum Pathol; 1998 Apr; 29(4):383-9. PubMed ID: 9563789
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?
Osazuwa-Peters N
Vaccine; 2013 Nov; 31(47):5500-5. PubMed ID: 24095883
[TBL] [Abstract][Full Text] [Related]
18. Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: A literature review.
Maver PJ; Poljak M
Vaccine; 2018 Aug; 36(36):5416-5423. PubMed ID: 28801154
[TBL] [Abstract][Full Text] [Related]
19. Vaccines against human papillomavirus infections: protection against cancer, genital warts or both?
Joura EA; Pils S
Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S125-S127. PubMed ID: 28034371
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus, cancer and vaccination.
Heard I
Curr Opin HIV AIDS; 2011 Jul; 6(4):297-302. PubMed ID: 21519247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
